Logo image of SQNS

SEQUANS COMMUNICATIONS-ADR (SQNS) Stock Fundamental Analysis

NYSE:SQNS - New York Stock Exchange, Inc. - US8173233060 - ADR - Currency: USD

2.42  -0.05 (-2.02%)

Fundamental Rating

4

Taking everything into account, SQNS scores 4 out of 10 in our fundamental rating. SQNS was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. SQNS has an average financial health and profitability rating. While showing a medium growth rate, SQNS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SQNS had positive earnings in the past year.
SQNS had a negative operating cash flow in the past year.
SQNS had negative earnings in 4 of the past 5 years.
In the past 5 years SQNS always reported negative operating cash flow.
SQNS Yearly Net Income VS EBIT VS OCF VS FCFSQNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

SQNS has a better Return On Assets (54.07%) than 98.15% of its industry peers.
SQNS has a Return On Equity of 103.14%. This is amongst the best in the industry. SQNS outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 54.07%
ROE 103.14%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQNS Yearly ROA, ROE, ROICSQNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

Looking at the Profit Margin, with a value of 154.81%, SQNS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Gross Margin of SQNS (75.54%) is better than 92.59% of its industry peers.
In the last couple of years the Gross Margin of SQNS has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 154.81%
GM 75.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.23%
GM growth 5Y13.49%
SQNS Yearly Profit, Operating, Gross MarginsSQNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

More info and screens

4

2. Health

2.1 Basic Checks

SQNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for SQNS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SQNS Yearly Shares OutstandingSQNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
SQNS Yearly Total Debt VS Total AssetsSQNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.39 indicates that SQNS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SQNS (2.39) is worse than 62.96% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that SQNS is not too dependend on debt financing.
SQNS has a Debt to Equity ratio of 0.01. This is in the better half of the industry: SQNS outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACCN/A
WACC16.7%
SQNS Yearly LT Debt VS Equity VS FCFSQNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 2.21 indicates that SQNS has no problem at all paying its short term obligations.
SQNS has a worse Current ratio (2.21) than 70.37% of its industry peers.
SQNS has a Quick Ratio of 2.13. This indicates that SQNS is financially healthy and has no problem in meeting its short term obligations.
SQNS's Quick ratio of 2.13 is in line compared to the rest of the industry. SQNS outperforms 51.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.13
SQNS Yearly Current Assets VS Current LiabilitesSQNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 267.04% over the past year.
Looking at the last year, SQNS shows a quite strong growth in Revenue. The Revenue has grown by 9.34% in the last year.
SQNS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.56% yearly.
EPS 1Y (TTM)267.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.09%
Revenue 1Y (TTM)9.34%
Revenue growth 3Y-10.27%
Revenue growth 5Y3.56%
Sales Q2Q%130.04%

3.2 Future

SQNS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -43.96% yearly.
Based on estimates for the next years, SQNS will show a very strong growth in Revenue. The Revenue will grow by 38.47% on average per year.
EPS Next Y-142.97%
EPS Next 2Y-43.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.93%
Revenue Next 2Y38.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SQNS Yearly Revenue VS EstimatesSQNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
SQNS Yearly EPS VS EstimatesSQNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1.07, which indicates a rather cheap valuation of SQNS.
SQNS's Price/Earnings ratio is rather cheap when compared to the industry. SQNS is cheaper than 100.00% of the companies in the same industry.
SQNS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
SQNS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 1.07
Fwd PE N/A
SQNS Price Earnings VS Forward Price EarningsSQNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

SQNS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SQNS is cheaper than 99.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.22
SQNS Per share dataSQNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

SQNS's earnings are expected to decrease with -43.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SQNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANS COMMUNICATIONS-ADR

NYSE:SQNS (2/21/2025, 8:04:00 PM)

2.42

-0.05 (-2.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-11 2025-02-11/bmo
Earnings (Next)06-16 2025-06-16/bmo
Inst Owners60.59%
Inst Owner Change-99.86%
Ins Owners3.73%
Ins Owner ChangeN/A
Market Cap149.89M
Analysts82.86
Price Target7.65 (216.12%)
Short Float %0.71%
Short Ratio0.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)424.37%
Min EPS beat(2)-12.04%
Max EPS beat(2)860.78%
EPS beat(4)3
Avg EPS beat(4)219.26%
Min EPS beat(4)-12.04%
Max EPS beat(4)860.78%
EPS beat(8)5
Avg EPS beat(8)104.31%
EPS beat(12)8
Avg EPS beat(12)91.26%
EPS beat(16)12
Avg EPS beat(16)73.08%
Revenue beat(2)2
Avg Revenue beat(2)54.2%
Min Revenue beat(2)2.52%
Max Revenue beat(2)105.88%
Revenue beat(4)3
Avg Revenue beat(4)26.89%
Min Revenue beat(4)-17.93%
Max Revenue beat(4)105.88%
Revenue beat(8)3
Avg Revenue beat(8)2.19%
Revenue beat(12)4
Avg Revenue beat(12)0.99%
Revenue beat(16)4
Avg Revenue beat(16)-0.84%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-20.83%
EPS NQ rev (3m)-383.33%
EPS NY rev (1m)-26.67%
EPS NY rev (3m)-26.67%
Revenue NQ rev (1m)10.77%
Revenue NQ rev (3m)-57.14%
Revenue NY rev (1m)-9.64%
Revenue NY rev (3m)-9.64%
Valuation
Industry RankSector Rank
PE 1.07
Fwd PE N/A
P/S 4.08
P/FCF N/A
P/OCF N/A
P/B 2.72
P/tB 3.02
EV/EBITDA 1.22
EPS(TTM)2.26
EY93.39%
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.59
BVpS0.89
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 54.07%
ROE 103.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 154.81%
GM 75.54%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.23%
GM growth 5Y13.49%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.01
Cap/Depr 30.76%
Cap/Sales 53.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.13
Altman-Z 2.39
F-Score6
WACC16.7%
ROIC/WACCN/A
Cap/Depr(3y)155.64%
Cap/Depr(5y)176.42%
Cap/Sales(3y)59.7%
Cap/Sales(5y)52.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)267.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.09%
EPS Next Y-142.97%
EPS Next 2Y-43.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.34%
Revenue growth 3Y-10.27%
Revenue growth 5Y3.56%
Sales Q2Q%130.04%
Revenue Next Year-1.93%
Revenue Next 2Y38.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-166.81%
OCF growth 3YN/A
OCF growth 5YN/A